Best Practices in Data Sharing between Ryan White HIV/AIDS Program Recipients and HIV Surveillance
Approaches and best practices in data sharing.
Resource (Conference Presentation) updated 09/14/2023
Approaches and best practices in data sharing.
Resource (Conference Presentation) updated 09/14/2023
Discussion of technical assistance provided to nine states on HIV and OUD system barriers, lessons learned, and sustainable strategies that states are using to address challenges.
Resource (Conference Presentation) updated 09/14/2023
Discussion of diverse partnerships developed to successfully treat a homeless population with addiction and newly diagnosed HIV as well as the service delivery challenges faced by an out-of-state Part C clinic.
Resource (Conference Presentation) updated 09/14/2023
Description of how an EHE program partnered with an emergency department and other stakeholders to reduce the time to ART from over 30 days to three days or same-day rapid ART.
Resource (Conference Presentation) updated 09/14/2023
Presentation of the New Haven/Fairfield Ryan White Part A Program's EHE process to recruit faith leaders, establish a guiding coalition, support a “by them, for them” planning process, and identify public and private funding resources.
Resource (Conference Presentation) updated 09/14/2023
Resource updated 10/24/2023
Resource updated 05/11/2023
Resource updated 12/19/2023
Resource updated 10/18/2023
Resource updated 05/10/2023
Resource from the RWHAP Best Practices Compilation updated on 11/13/2023
RWHAP Technical Assistance Provider updated on 07/09/2024
Resource from the RWHAP Best Practices Compilation updated on 11/14/2023
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
Resource from the RWHAP Best Practices Compilation updated on 01/07/2024
Virginia quality improvement program that identifies access to medication barriers and provides emergency medication supplies to people with HIV if no timely access is secured.
Resource (Conference Presentation) updated 09/14/2023
HHS process for development of the “I Am a Work of ART” viral suppression campaign, in collaboration with community partners. of the National HIV/AIDS Strategy.
Resource (Conference Presentation) updated 09/14/2023
Resource updated 04/12/2024